Cipla is a global pharmaceutical company whose goal is to ensure that no patient shall be denied access to high quality & affordable medicine and support.
Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet every day needs of all the patients.
Turnover*USD 2 Billion
Founder (1898-1972)Dr. K.A. Hamied
Non-Executive ChairmanDr. Y.K. Hamied
Non-Executive Vice-ChairmanMr. M.K. Hamied
Cipla Limited, Cipla House, Peninsula Business Park,
Ganpatrao Kadam Marg, Lower Parel, Mumbai 400 013
Equity Shares: BSE Limited and National Stock Exchange of India Limited
Global Depository Receipts: Luxembourg Stock Exchange
- Continuous innovation in R & D with 20+ world firsts.
- Over 1,000 products across various therapeutic categories, with 50+ dosage forms.
- Presence in over 100 countries
US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among others
Mumbai Central Office: +91 22 23082891, +91 22 23095521
Peninsula Business Park Office: +91 22 24826000, +91 22 24826701, +91 22 24826300